. /.  WORLD TRADE  
ORGANIZATION   
G/TBT/N/CAN/369 
6 August 2012  
 (12-4318) 
Committee on Technical Barriers to Trade Original:   English/ 
 French 
 
 
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6 
 
1. Notifying Member:  CANADA  
If applicable, name of local governme nt involved (Article 3.2 and 7.2):     
2. Agency responsible:  Department of Health 
Name and address (including telephone and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above :  Canadian Enquiry 
Point, 200-270 Albert Street, Ottawa, Onta rio, Canada K1P 6N7 Tel.:  +1 613 238 3222, 
Fax:  +1 613 569 7808, Email:  enquirypoint@scc.ca  
3. Notified under Article 2.9.2 [X], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:   
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in addition, where applicable):  Barley food products 
(ICS: 67.060) 
5. Title, number of pages and language(s) of the notified document:  Summary of Health 
Canada's Assessment of a He alth Claim about Barley Pr oducts and Blood Cholesterol 
Lowering (6 pages, in English and French).      
6. Description of content:  Health Canada's Food Directorate received a submission requesting 
approval for the use of a ther apeutic claim linking barley beta-glucan to blood cholesterol 
lowering.  Health Canada has concluded that scientific evidence exists in support of the 
therapeutic clai m linking barley grain products to a reduc tion of blood cholesterol.  Based on 
the scientific evidence available, feedback fro m the petitioner and consideration of decisions 
made in other jurisdictions, it is Health Canada 's opinion that the therapeutic claim statements 
set out are substantiated in rela tion to barley grain products wh en specific conditions for the 
food carrying the claim are met. The notified document summariz es Health Canada's basis for 
the acceptance of a health cl aim about barley products a nd cholesterol lowering. The 
publication of this document would permit the marketing of barley food products carrying a 
cholesterol lowering cl aim provided that these foods meet the conditions set out in the 
document.  
7. Objective and rationale, including the na ture of urgent problems where applicable:  
Protection of human health, as well as to allo w the communication of a substantiated health 
benefit.  G/TBT/N/CAN/369 
Page 2  
 
  8. Relevant documents:   Health Canada's Health Claim Assessments on Health Canada's 
Nutrition and Health Claims Website. 
http://hc-sc.gc.ca/fn-an/label-etiquet/cl aims-reclam/assess-evalu/index-eng.php  (English) 
http://hc-sc.gc.ca/fn-an/label-etiquet/cl aims-reclam/assess-evalu/index-fra.php  (French) 
9. Proposed date of adoption:   
Proposed date of entry into force:    12 July 2012 
10. Final date for comments:  28 September  2012 
11. Text available from:  National enquiry point [X], or address, telephone and fax 
numbers, e-mail and web-site addres ses, if available of the other body:   The electronic 
version of "Summary of Health Canada's As sessment of a Health Claim about Barley 
Products and Blood Cholesterol Lowe ring" can be downloaded at: 
http://www.hc-sc.gc.ca/fn-an/label-etiquet/cl aims-reclam/assess-eva lu/barley-orge-eng.php  
(English)  
http://www.hc-sc.gc.ca/fn-an/label-etiquet/cl aims-reclam/assess-eva lu/barley-orge-fra.php  
(French)